These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
397 related items for PubMed ID: 15334548
41. 5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer. Trojan J, Brieger A, Raedle J, Esteller M, Zeuzem S. Gut; 2000 Aug; 47(2):272-6. PubMed ID: 10896921 [Abstract] [Full Text] [Related]
42. Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer. Baffa R, Santoro R, Bullrich F, Mandes B, Ishii H, Croce CM. Clin Cancer Res; 2000 Apr; 6(4):1372-7. PubMed ID: 10778965 [Abstract] [Full Text] [Related]
47. A region of allelic imbalance in 1q31-32 in primary breast cancer coincides with a recombination hot spot. Benítez J, Osorio A, Barroso A, Arranz E, Díaz-Guillén MA, Robledo M, Rodríguez de Córdoba S, Heine-Suñer D. Cancer Res; 1997 Oct 01; 57(19):4217-20. PubMed ID: 9331079 [Abstract] [Full Text] [Related]
49. Frequent loss of heterozygosity at the 19p13.3 locus without LKB1/STK11 mutations in human carcinoma metastases to the brain. Sobottka SB, Haase M, Fitze G, Hahn M, Schackert HK, Schackert G. J Neurooncol; 2000 Sep 01; 49(3):187-95. PubMed ID: 11212897 [Abstract] [Full Text] [Related]
50. Two regions of deletion in 9p23-24 in sporadic breast cancer. An HX, Claas A, Savelyeva L, Seitz S, Schlag P, Scherneck S, Schwab M. Cancer Res; 1999 Aug 15; 59(16):3941-3. PubMed ID: 10463588 [Abstract] [Full Text] [Related]
51. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Tsuda H, Callen DF, Fukutomi T, Nakamura Y, Hirohashi S. Cancer Res; 1994 Jan 15; 54(2):513-7. PubMed ID: 8275489 [Abstract] [Full Text] [Related]
52. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Driouch K, Prydz H, Monese R, Johansen H, Lidereau R, Frengen E. Oncogene; 2002 Mar 14; 21(12):1832-40. PubMed ID: 11896615 [Abstract] [Full Text] [Related]
53. Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Wang VW, Bell DA, Berkowitz RS, Mok SC. Cancer Res; 2001 May 15; 61(10):4169-74. PubMed ID: 11358841 [Abstract] [Full Text] [Related]
54. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Kerangueven F, Noguchi T, Coulier F, Allione F, Wargniez V, Simony-Lafontaine J, Longy M, Jacquemier J, Sobol H, Eisinger F, Birnbaum D. Cancer Res; 1997 Dec 15; 57(24):5469-74. PubMed ID: 9407952 [Abstract] [Full Text] [Related]
55. Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast. Tran Y, Benbatoul K, Gorse K, Rempel S, Futreal A, Green M, Newsham I. Oncogene; 1998 Dec 31; 17(26):3499-505. PubMed ID: 10030674 [Abstract] [Full Text] [Related]
56. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer. Fromont G, Valeri A, Cher M, Pontes JE, Vallancien G, Validire P, Latil A, Cussenot O. Prostate; 2005 Dec 01; 65(4):341-6. PubMed ID: 16015610 [Abstract] [Full Text] [Related]
57. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer. Ueda T, Komiya A, Suzuki H, Shimbo M, Sakamoto S, Imamoto T, Akakura K, Shiraishi T, Ichikawa T. Prostate; 2005 Aug 01; 64(3):265-71. PubMed ID: 15717310 [Abstract] [Full Text] [Related]